UndervaluedStocks Tuesday, 04/17/18 12:40:10 AM Re: None 0 Post # of 78057 For new investors, current status of Silicon Valley biotech Arrayit Corporation (ARYC) is as follows: a) Arrayit is strengthening its relationship with UDSA via validation of the stand alone position of their technology byproduct for testing against food born pathogens b) Sales of products and services on the rise c) Most of the Taub Case has been gutted with only one small phase left as extended by the Court to allow Plaintiffs to provide evidence of damage (which in discovery has not shown any measure of their plead) d) Arrayit continues to support the audit process in order to provide the public with the best transparency suitable for the elevating the status of the company and its PPS. In order to fully comply with the above process, they opt to hire specialists to provide RRBB with the best evidence of their financial and securities value during the last year and a half of their recovery e) The perceived delay in the completion of the audit was due to RRBB internal issues, which in a large auditing firm such as theirs, is not uncommon. However, everything is now on track to filing very soon f) Rumors of discussions for acquisition may or may not be true, however, the depth of the audit begs for inferring that the possibility of said discussions may in fact be true. As in any reality, without direct knowledge any analysis is speculation until proven true. The advice to any one who seeks it is to do your own DD and if you believe that this company does have the state of the art technology and products that merit such a demand as being Tweeted, then stay the course and see where it leads.